NCT00774904View on ClinicalTrials.gov

Adiponectin and Insulin Resistance in Diabetic Nephropathy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

November 30, 2007

Conditions
Diabetic Nephropathy
Interventions
DRUG

Losartan

Angiotensin II Type 1 Receptor Blockers

Trial Locations (1)

201900

Shanghai No.3 people's hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Jiao Tong University School of Medicine

OTHER

lead

Xi'an Jiaotong University

OTHER

NCT00774904 - Adiponectin and Insulin Resistance in Diabetic Nephropathy | Biotech Hunter | Biotech Hunter